Table 2.

Associations between measures of ART adherence readiness and starting ART and remaining on ART for 3 months

	Started ART			On ART for first 3 months			Optimal (85+ %) ART adherence
	Yes	No	P	Yes	No	P	Yes	No	P
Intervention group only	N = 76	N = 7		N = 55	N = 28		N = 29	N = 54
Adherence [mean (SD)] in 1st practice trial (range: 0–100%)	93.2% (14.9)	44.0% (−)	0.002	94.0% (15.5)	87.9% (16.6)	0.155	94.1% (19.7)	91.4% (12.9)	.493
Only needed 1 practice trial to demonstrate readiness	84.2%	0%	0.000	90.9%	50.0%	0.000	89.7%	70.4%	.057
Demonstrated readiness in pre-ART practice trial phase	92%	14%	0.000	98%	61%	0.000	96.6%	79.6%	.049
Total sample	N = 166	N = 10		N = 124	N = 52		N = 62	N = 114
Provider estimate of ART adherence [mean (SD); range: 0–100%]	84.2% (10.1)	69.0% (18.8)	0.031	84.7% (10.2)	80.1% (13.1)	0.017	87.5% (7.8)	81.1% (12.2)	.000
HIV Medication Readiness Scale [mean (SD); range: 0–40]	26.8 (9.7)	23.6 (14.2)	0.497	26.4 (9.7)	27.3 (10.9)	0.541	28.5 (8.2)	25.7 (10.8)	.056
Transtheoretical model of readiness to change [mean (SD); range: 1–4]	3.4 (0.92)	2.9 (1.2)	0.460	3.4 (0.9)	3.2 (1.3)	0.299	3.8 (0.4)	3.2 (1.1)	.000